The upfront payment for all shares of the company, which specializes in technologies for heart recovery, is valued at $16.6B.

Related Keywords

Massachusetts , United States , Johnson Medtech , Waqaas Al Siddiq , Ashley Mcevoy , Michaelr Minogue , Johnson , Abiomed , Drug Administration ,